Programs and Activities
Center for Leadership, Ethics & Equity
The LE&E Center will bring together existing initiatives of The ACG Institute focused on leadership training and consolidate new programs and research funding along with transformational tools and experiences. The programs under the new LE&E Center include:
- The ACG Young Physician Leadership Scholars Program
- The ACG Advanced Leadership Development Program
- Prescription for Success: Careers in Medicine – ACG High School Visit
- ACG Visiting Scholar in Equity, Diversity & Ethical Care
- The ACG Health Equity Research Award
ACG Young Physician Leadership Scholars Program
The Young Physician Leadership Scholars Program is an intensive program that provides a focused cohort of young GI clinicians the opportunity to build foundational leadership and advocacy skill and to develop executive decision-making capabilities. Motivated young physicians are brought together to exchange ideas as they work to enhance critical thinking and comprehend organizational behavior. The program combines online learning, participation in legislative advocacy, and live course work at the ACG Annual Meeting.
ACG Edgar Achkar Visiting Professorship Program
The goal of the ACG Edgar Achkar Visiting Professorship Program, which honors former ACG Institute Director, Edgar Achkar, MD, MACG, is to enable GI fellowship programs to have high-quality visiting professors to bolster the training program by providing lectures, small group discussions, and one-on-one visits with trainees and faculty. You choose the speaker, the Institute covers the travel costs and honorarium.
Since the founding of the ACG Institute in 1994, funding has been provided to 676 investigators, totaling more than $24 million for research directly relating to the practice of clinical gastroenterology. Looking ahead, the ACG Institute’s continued investment in career development awards and funding for GI fellows-in-training will foster clinical innovations in gastroenterology and hepatology that will improve patient care and strengthen the capabilities of practitioners. The College is proud of the achievements of its funded investigators and plans to invest more fully in their leadership and success.
With the diagnosis and treatment of liver disease undergoing dramatic change, new therapies have created the need for comprehensive educational opportunities. Initiated as Hepatitis School, the new Hepatology School encompasses treatment of frequently diagnosed liver disease states. The ACG’s Hepatology School is designed to better enable clinical gastroenterologists and primary care physicians to triage, treat, and refer patients more efficiently.
IBD School was first introduced in 2017 and is modelled after the highly successfully Hepatology School—a day-long educational program that combines an immersion in IBD management with a clinical update on new therapeutic and monitoring approaches. The goals of this course are to improve clinical judgment and to address the art and science of IBD management.
Functional GI Disorders School
Functional GI diseases are among the most commonly diagnosed in the United States. ACG’s Functional GI School addresses all aspects of treatment for a wide variety of conditions and seeks to empower attendees not only with new diagnostic knowledge, but also the ability to better communicate with their patients about diagnosis and treatment. Enrollment is open to all clinicians.
Evidence-Based Monographs and Reviews
The Functional Bowel Disease Task Force was convened by the ACG Institute to review the meta-analysis of new RCT research and evaluate the analysis utilizing the GRADE system of evaluation. This criterion, which is a best practice means of evaluating data, was used in creating the updated recommendations for 2018.
The College and the ACG Institute published a new evidence-based systematic review on the management of Inflammatory Bowel Disease as a supplement to The American Journal of Gastroenterology (AJG) for April 2011. This clinical monograph, based on a comprehensive meta-analysis, offers new graded recommendations on medical management of IBD.